RHÖN-KLINIKUM Future Growth
Future criteria checks 1/6
RHÖN-KLINIKUM is forecast to grow earnings and revenue by 7.5% and 2.1% per annum respectively. EPS is expected to grow by 9.6% per annum. Return on equity is forecast to be 3.5% in 3 years.
Key information
7.5%
Earnings growth rate
9.6%
EPS growth rate
| Healthcare earnings growth | 20.9% |
| Revenue growth rate | 2.1% |
| Future return on equity | 3.5% |
| Analyst coverage | Low |
| Last updated | 17 Sep 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,657 | 50 | 28 | N/A | 2 |
| 12/31/2025 | 1,596 | 44 | 25 | N/A | 2 |
| 12/31/2024 | 1,534 | 39 | 39 | N/A | 2 |
| 9/30/2024 | 1,835 | 45 | N/A | N/A | N/A |
| 6/30/2024 | 1,802 | 47 | 69 | 142 | N/A |
| 3/31/2024 | 1,767 | 43 | N/A | N/A | N/A |
| 12/31/2023 | 1,735 | 39 | 46 | 109 | N/A |
| 9/30/2023 | 1,714 | 32 | N/A | N/A | N/A |
| 6/30/2023 | 1,694 | 26 | -11 | 43 | N/A |
| 3/31/2023 | 1,690 | 30 | N/A | N/A | N/A |
| 12/31/2022 | 1,661 | 25 | 2 | 60 | N/A |
| 9/30/2022 | 1,640 | 30 | N/A | N/A | N/A |
| 6/30/2022 | 1,628 | 32 | -18 | 48 | N/A |
| 3/31/2022 | 1,602 | 28 | N/A | N/A | N/A |
| 12/31/2021 | 1,591 | 28 | 20 | 98 | N/A |
| 9/30/2021 | 1,557 | 15 | N/A | N/A | N/A |
| 6/30/2021 | 1,554 | 14 | 23 | 117 | N/A |
| 3/31/2021 | 1,549 | 7 | N/A | N/A | N/A |
| 12/31/2020 | 1,546 | 1 | 16 | 113 | N/A |
| 9/30/2020 | 1,537 | 8 | 20 | 113 | N/A |
| 6/30/2020 | 1,532 | 19 | 10 | 100 | N/A |
| 3/31/2020 | 1,513 | 31 | -28 | 63 | N/A |
| 12/31/2019 | 1,481 | 43 | -67 | 47 | N/A |
| 9/30/2019 | 1,436 | 40 | -61 | 91 | N/A |
| 6/30/2019 | 1,413 | 52 | -95 | 74 | N/A |
| 3/31/2019 | 1,394 | 47 | -134 | 46 | N/A |
| 12/31/2018 | 1,390 | 49 | -114 | 50 | N/A |
| 9/30/2018 | 1,411 | 55 | -114 | 24 | N/A |
| 6/30/2018 | 1,385 | 36 | N/A | 54 | N/A |
| 3/31/2018 | 1,374 | 37 | N/A | 63 | N/A |
| 12/31/2017 | 1,362 | 35 | N/A | 80 | N/A |
| 9/30/2017 | 1,340 | 2 | N/A | 69 | N/A |
| 6/30/2017 | 1,330 | 4 | N/A | 87 | N/A |
| 3/31/2017 | 1,334 | 14 | N/A | 96 | N/A |
| 12/31/2016 | 1,319 | 56 | N/A | 109 | N/A |
| 9/30/2016 | 1,291 | 101 | N/A | 114 | N/A |
| 6/30/2016 | 1,276 | 105 | N/A | 101 | N/A |
| 3/31/2016 | 1,251 | 103 | N/A | 80 | N/A |
| 12/31/2015 | 1,240 | 85 | N/A | 67 | N/A |
| 9/30/2015 | 1,250 | 66 | N/A | 63 | N/A |
| 6/30/2015 | 1,248 | 62 | N/A | 54 | N/A |
| 3/31/2015 | 1,300 | -138 | N/A | 55 | N/A |
| 12/31/2014 | 1,666 | 1,226 | N/A | 49 | N/A |
| 9/30/2014 | 2,171 | 1,245 | N/A | 67 | N/A |
| 6/30/2014 | 2,661 | 1,250 | N/A | 153 | N/A |
| 3/31/2014 | 3,098 | 1,459 | N/A | 209 | N/A |
| 12/31/2013 | 3,223 | 87 | N/A | 210 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: RHKJ.F's forecast earnings growth (7.5% per year) is above the savings rate (2.6%).
Earnings vs Market: RHKJ.F's earnings (7.5% per year) are forecast to grow slower than the US market (15.4% per year).
High Growth Earnings: RHKJ.F's earnings are forecast to grow, but not significantly.
Revenue vs Market: RHKJ.F's revenue (2.1% per year) is forecast to grow slower than the US market (8.9% per year).
High Growth Revenue: RHKJ.F's revenue (2.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: RHKJ.F's Return on Equity is forecast to be low in 3 years time (3.5%).